Yomi Pharma is developing a new targeted therapy against EGFR, an onco-receptor responsible for the aggressiveness of certain lung cancers.
Estimated return of 2100% with potential exit in 2030
Industry - HealthTech
Raising- 800.000 EUR
Valuation (pre-money) - 5.000.000 EUR
Company and product stage - Prototype/preclinical
What problem Yomi Pharma is solving?
Yomi Pharma is developing a new targeted therapy against EGFR, an onco-receptor responsible for the aggressiveness of certain lung cancers. All current treatments end up failing, leaving patients without a solution. To address this significant medical need, Yomi is leveraging a patented technology by exploiting the properties of a peptide derived from sortilin, a protein capable of inhibiting EGFR even after the appearance of mutations responsible for tumor recurrence. Driven by promising preclinical results, Yomi is today raising €800,0000, of which €335K is secured.
What is Yomi Pharma market potential?
Two strategic segments with strong medical and commercial impact. YomiPep fits into current treatment lines:
In the 2nd line of treatment after failure of targeted anti-EGFR therapies, for common mutations (e.g. L858R, Del19): 28,000 patients/year and a turnover potential of $3.4 billion
In first-line treatment for rare EGFR mutations, currently under-treated: 11,000 patients/year and a potential turnover of $1.1 billion
Le Rouge Français on Tudigo
The plant-based alternative to petrochemical dyes: disruptive innovation in the beauty and color industry.
Estimated return of up to 470%
Industry - Beauty industry
Company and product stage - Already present in 15 countries with more than 100 selective points of sale, the brand will open its first flagship boutique in Paris (Marais district) in the summer of 2025. It is also starting its expansion towards China and the United Arab Emirates.
What problem Le Rouge Français is solving?
Le Rouge Français is a premium, organic, vegan and 100% natural cosmetics company . But above all, it is an industrial biotech company at the forefront of dyeing innovation. Its technology makes it possible to produce plant-based colors from plants grown in ethical and sustainable sectors, without any use of petrochemical solvents.
In 5 years, Le Rouge Français has structured its R&D, secured 12 patents, launched over 100 products and signed major contracts with Nocibé, Douglas, Neiman Marcus, Credo Beauty, etc.
Already present in 15 countries with more than 100 selective points of sale, the brand will open its first flagship boutique in Paris (Marais district) in the summer of 2025. It is also starting its expansion towards China and the United Arab Emirates.
Le Rouge Français, through these different verticals, notably applies its patents by offering a complete range of cosmetics to the highest standards:
- 100% plant-based pigments: derived from over 150 dye plants (Madder, Indigo, Roucou, etc.), equivalent to a natural Pantone color chart
- Ultra-pure formulas: 100% natural, 75% organic, no titanium dioxide, no cochineal, no beeswax
- Eco-designed packaging : cases made from cut glass or bio-sourced (castor oil), 0% disposable plastic, 100% recyclable
- Ethical and endemic sectors : Provence, Sri Lanka (agroforestry), Latin America
- Certifications : ORGANIC (ECOCERT), VEGAN (PETA), recyclable
A global market worth €300 billion , in full transformation towards clean beauty.
- €11 billion for the French market
- Sustained growth driven by demand for naturalness and transparency
- Clean Beauty : a fundamental trend combining performance and sustainability
- Targeted adjacent markets : automotive, textiles, spirits, eyewear, agri-food (POC in progress)
Daphne Solutions on Crowdcube
Daphne Solutions is a Swiss climate tech startup, spun off from Daphne Technology, to bring carbon capture technology to the maritime sector. Based on their technology and licensed patents, they are focused on developing modular carbon capture systems, facilitating regulatory compliance and sustainable innovation.
Industry - Climate tech
Company and product stage - Backed by global leaders: Aramco, Shell, Trafigura, and J.P. Morgan.
What problem Daphne Solutions is solving?
Problem- The marine sector emits ~3% of global CO₂. Most vessels can be retrofitted, but no scalable CCS system exists today — making IMO’s 2050 net-zero goal difficult to achieve.
Solution -We’re developing a compact onboard system for ships that captures CO₂ using licensed membrane-solvent tech (targeting TRL 8). The system aims to lower operating costs by using waste heat and to minimize space requirements through a scalable, modular design.
The Onboard Carbon Capture Market is currently valued at approximately $2B in 2025, with an expected CAGR of 15% from 2025 to 2033.
What is Daphne Solutions market potential?
The Onboard Carbon Capture Market is currently valued at approximately $2B in 2025, with an expected CAGR of 15% from 2025 to 2033.
Anastasis Biotec on Crowdcube
Anastasis Biotec Ltd is developing advancements in cancer treatment with its focus on Antennapedia Transporter Protein (ANTP) for the delivery of human protein therapeutics. The company is dedicated to developing two proprietary drug candidates targeting advanced and difficult to treat cancers.
Industry - HealthTech
Valuation (pre-money) - 28,116,855 GDP
Company and product stage - Developing two proprietary drug candidates targeting advanced cancer and cancer stem cells.
What problem Anastasis Biotec is solving?
Problem - Cancer is one of the leading causes of death worldwide, close to 20 million new cases diagnosed in 2022. Current cancer therapies are limited by their inability to effectively deliver treatments directly to tumour sites, reducing the efficacy and increasing the resistance of cancer treatments.
Solution - Most patients with cancer have either Mastermind/Notch or P53 mutations and may be suitable for treatment by the Company’s drug candidates (S4 and AB1). Our products are new human therapeutic proteins, which we believe are different and designed to offer notable differences compared to existing or in-development therapies.
What is Anastasis Biotec market potential?
Global precision oncology market is estimated at USD 115.32 million in 2024.
Subdron on SeedBlink
3D Scanning of underwater structures
Industry - 3D Scanning
Raising - 1.900.000 EUR
Company and product stage - Secured 38 Letters of Intent (LoIs) from ship owners, authorities, and inspection companies.
What problem Subdron is solving?
Subdron addresses the inefficiencies and risks of underwater inspections in the maritime industry. Biofouling on vessels increases emissions and operating costs significantly—by up to €5.3 million per ship annually. Inspections of ships, ports, and critical underwater infrastructure are necessary but are largely conducted by divers or manually operated ROVs, which are risky, costly, and yield poor-quality, inconsistent data. Only 0.9% of vessels entering EU ports are inspected, due to the inefficiencies of current methods. Subdron is solving the core issues of safety, data quality, environmental limitations, and cost by automating and improving the inspection process.
Subdron provides a fully autonomous underwater inspection system that integrates precision navigation (under 5 cm error), AI-based data processing, and intuitive 3D visualization tools. It works with existing underwater robots and upgrades them with autonomous capabilities and high-resolution sensors that function even in low-visibility conditions. This tech enables fast, high-quality, and repeatable inspections while eliminating the need for human divers or remote operators. The system can identify structural issues and biofouling in real-time and generate actionable reports.
What is Subdron market potential?
Subdron targets a total addressable market (TAM) of €78 billion across several sectors:
- €32B: Seaports and merchant ships (current focus).
- €46B: Hydropower dams, offshore industry, and underwater robotics (future expansion).
- The European Serviceable Available Market (SAM) is €10.1 billion, with €2 billion specifically addressable in Europe. Deploying 50 systems across key ports is projected to generate €40 million in revenue.
Nebeus on Seedrs / Republic
Where crypto meets the real world: transact, borrow against and grow your digital assets effortlessly.
Industry - Crypto
Raising - 3,000,010 EUR
Company and product stage - 6x YoY Revenue Growth reaching €2.2M
What problem Nebeus is solving?
Nebeus is building the future of finance by connecting crypto with traditional money. With 6x revenue growth in 2024 and licenses in the UK, Spain & Argentina, we empower businesses and digital nomads with everyday crypto payments, global payouts, and card solutions.
What is Nebeus market potential?
Stablecoins hit $27tn in transfer volume in 2024, surpassing Visa and Mastercard combined. Yet global businesses still lack reliable cross-border solutions. With 1.57bn freelancers by 2027 and a €3tn finance market, Nebeus delivers a regulated, crypto-native stack built to scale.
Musqet on Seedrs / Republic
Musqet's mission is to be a next generation ePOS, payments & Bitcoin Lightning business for merchants.
Industry - Crypto/ POS
Raising - 1,350,007 GBP
Company and product stage - £600m potential customer pipeline to onboard in 2025
What problem Musqet is solving?
Musqet is on a mission to become a next-generation ePOS and payments platform, poised for exceptional growth and success. By seamlessly integrating traditional payment methods with Bitcoin Lightning infrastructure, Musqet aims to empower merchants to accept borderless, instant payments both in-store and online.
What is Musqet market potential?
Global payments revenues are expected to grow from approximately $2.4 trillion in 2023 to $3.1 trillion by 2028, reflecting a 5% CAGR, which adds roughly $700 billion in incremental revenue (Mckinsey).
Meanwhile, UK Finance reports that in 2023 61% of UK transactions were card-based, with cash usage declining to 12%, while digital wallet adoption climbed to 42%, signalling a broader shift to electronic payments.
This backdrop underscores a global Total Addressable Market measured in the tens of trillions of dollars across card present and online payment flows.
Against this dynamic and still‑fragmented market landscape, currently dominated by players like Square, Stripe, and Adyen, we believe Musqet is well‑positioned to capture meaningful market share.
GREEN CITY SOLUTIONS on Companisto
Regenerative bio-air filter with vertical moss mats and integrated sensor technology.
Estimated return of 218%
Industry - Sustainable technology
Raising - 650,000 EUR
Valuation (pre-money) - 20,700,000 EUR
Company and product stage - Green City Solutions has secured long-term contracts with cities and companies, including a €450K deal in Hamburg and €350K with the city of Differdingen.
What problem GREEN CITY SOLUTIONS is solving?
Urban areas face dangerously high air pollution levels, with 95% of city dwellers breathing harmful air. Climate change is intensifying the crisis, contributing to over 10 million deaths worldwide in 2024. Regulatory pressure and ESG requirements are increasing for businesses and municipalities. Traditional green infrastructure cannot meet the scale or efficiency needed to address these urgent environmental challenges.
Green City Solutions has developed the world’s first biotech air filter using active mosses enhanced by IoT and AI. Their moss-based products—CityTree, CityBreeze, and WallBreeze—filter fine dust, cool urban air, and improve humidity. These units offer 10x more efficiency than traditional plants in the same footprint and provide real-time environmental data. The solution is scalable, low-maintenance, and delivers quantifiable ESG benefits.
What is GREEN CITY SOLUTIONS market potential?
The company targets a €130 billion European market across cities, ESG-driven companies, and the green construction sector. Key market segments include corporate social responsibility budgets (€15B), the green building sector (€69B), and outdoor marketing (€39B). Growth is supported by regulatory incentives and demand for climate-adaptive infrastructure. Their offering aligns with both climate goals and financial incentive programs like the EU LIFE initiative.
AQUAMONDIS on Fundernation
Green technology for natural blue from spirulina algae
Estimated return of 539%
Industry - Sustainable farming
Raising - 1.000.000 EUR
Valuation (pre-money) - 5.000.000 EUR
Company and product stage - first complete customer project with a construction customer in the Netherlands has already started in Q2 and will run until the end of July.
What problem Kitepower is solving?
Aquamondis will build a facility on the Cape Verde Islands to produce the microalgae spirulina under optimal conditions. The blue pigment phycocyanin will then be extracted from the algae.
Phycocyanin is the most important naturally occurring blue pigment for the food industry (market share approximately 95%). It is used as an additive to color foods such as snacks and beverages .
Spirulina algae, a superfood, has a phycocyanin content of up to 20%. It has been named " Best Food of the Future " by the UN and has numerous health benefits (e.g., anti-inflammatory effects, immune system strengthening, etc.).
Therefore, NASA and the European Space Agency ESA want to use spirulina as an important food source for long-term space missions.
The remaining amount of algae resulting from phycocyanin extraction can be further processed as a dietary supplement , but also for the pharmaceutical and cosmetics industries .
Due to the limited availability of phycocyanin, the product is traded at high prices. The upcoming bans on artificial colors in the EU and the US will cause demand to rise sharply in the coming years.
Spirulina is primarily marketed as a powder. Available market figures on commercial spirulina production and trade vary widely. However, there is consensus regarding the expected average annual growth rate , which is expected to be approximately 10% until 2030. The market volume is expected to increase from €436 million to approximately €1.05 billion between 2022 and 2030.
Corem on CrowdFundMe
Intuitive and efficient cloud platform for managing companies' human resources, developed to simplify and maximize the value of their human capital.
Industry - HRTech
Raising - 200.000 EUR
Valuation (pre-money) - 2,200,000 EUR
Company and product stage - 32 active customers: 28 in Italy, 2 in Spain and 2 in Portugal
Project and business model description of Corem.
Corem is the human resources management software designed to simplify and digitize the business processes of small and medium-sized businesses, such as the fragmented management of attendance, shifts, holidays, and documents.
Corem was born as a spin-off of Easy4cloud SPA, an incubator of the Redfish Group.
The company has developed a proprietary platform , built entirely in-house, accessible via the cloud from desktop and mobile, with a European-registered trademark and SIAE-protected source code. This direct control over each product line allows Corem to innovate rapidly, without relying on external suppliers.
Corem was created with the goal of giving HR teams, managers, and employees back time and clarity by offering an interface that shows each user only relevant information, in real time. The system dramatically reduces errors, unread emails, and operational misunderstandings.
Corem's proposal is based on three distinctive elements :
- A multilingual architecture designed for international expansion
- Internal marketing and sales management to ensure traceable growth
- A scalable SaaS model that has already achieved a renewal rate of over 80% in the Italian market.
The business model is based on recurring subscriptions for user licenses, to which one-time fees may be added for onboarding or any customizations. The cost structure remains low thanks to the cloud infrastructure and an in-house development team, allowing the company to maintain high margins as its customer base grows.
After consolidating its position in Italy, Corem activated its first commercial pipelines in Spain and Portugal in the first half of 2025, thus validating the first steps of its international roadmap.
Hydros Power on StartupXplore
Invest in the green hydrogen revolution for mobility
Industry - Renewable Energy
Raising - 360,000 EUR
Company and product stage - Hydros Power has validated its technology with a first pilot on an environmental inspection drone.
What problem Hydros Power is solving?
Hydros Power is a technology startup developing a complete ecosystem to accelerate the adoption of green hydrogen in mobility applications where lithium batteries do not offer a scalable solution (long recharge times, low autonomy, and short lifespan). These applications include logistics fleets, industrial machinery, heavy transport, refrigeration, and aerial vehicles.
Its proposal combines three key products:
STELION Powertrain: fuel cell systems that generate electricity with hydrogen and replace batteries in electric vehicles, drones, and refrigerated containers, improving productivity by up to 180% compared to battery-only solutions.
STELION Capsules: interchangeable high-pressure gaseous hydrogen storage capsules that allow plug & play refueling of vehicles in less than a minute, eliminating the need for pressurized hoses and cooling systems used in conventional hydrogen stations.
STELION Station: stations for generation, compression, and recharging of our storage and supply capsules, reducing the required pressure by 30% compared to a conventional hydrogen station and eliminating the need for a hydrogen distribution infrastructure, which unfortunately does not exist.
Hydros Power has validated its technology with a first pilot on an environmental inspection drone, where it tripled the autonomy offered by batteries. It is currently developing a hydrogen-powered refrigerated container in the Port of Valencia, in collaboration with the Port Authority and the European Institute of Innovation and Technology in its mobility branch. The latter also leads the current funding round as a lead investor.
Don’t miss out on amazing investment opportunities follow us on YouTube, LinkedIn and Facebook and learn more about crowdfunding on Crowdinform.com
We wish you a good day and successful investing!
CrowdInform